Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Co Diagnostics Inc

CODX
1,46
-0,13 (-8,18%)
Ultimo aggiornamento: 21:55:07
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202415:30PRNUSCo-Diagnostics, Inc. Submits First FDA 510(k) Application..
14/6/202413:35EDGAR2Form 8-K - Current report
28/5/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:01EDGAR2Form 8-K - Current report
09/5/202422:01PRNUSCo-Diagnostics, Inc. Reports First Quarter 2024 Financial..
25/4/202415:30PRNUSCo-Diagnostics, Inc. Announces First Quarter 2024 Earnings..
24/4/202415:30PRNUSCo-Diagnostics, Inc. to Host Booth and Deliver Presentation..
12/4/202415:30PRNUSCo-Diagnostics, Inc. Inaugurates New Manufacturing Facility..
04/4/202415:30PRNUSCo-Diagnostics, Inc. Appoints New President and Other..
21/3/202414:30PRNUSCo-Diagnostics, Inc. CEO Delivers Manufacturing and..
18/3/202414:30PRNUSCo-Diagnostics, Inc. CEO to Deliver Keynote Address at..
14/3/202421:01PRNUSCo-Diagnostics, Inc. Reports Full Year 2023 Financial..
07/3/202415:30PRNUSCo-Diagnostics, Inc. JV CoSara Receives Clearance from..
29/2/202415:30PRNUSCo-Diagnostics, Inc. Announces Fourth Quarter and Full Year..
01/2/202415:30PRNUSCo-Diagnostics, Inc. Shares List of Upcoming Industry..
03/1/202415:30PRNUSCo-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
27/12/202315:30PRNUSCo-Diagnostics, Inc. Completes Submission to FDA for Co-Dx..
29/11/202315:30PRNUSCo-Diagnostics, Inc. to Participate in the Piper Sandler..
27/11/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:01EDGAR2Form 8-K - Current report
09/11/202322:01PRNUSCo-Diagnostics, Inc. Reports Third Quarter 2023 Financial..
02/11/202314:30PRNUSCo-Diagnostics, Inc. Announces Additional Grant Award for..
31/10/202314:30PRNUSCo-Diagnostics, Inc. Shares List of Upcoming Industry..
26/10/202315:30PRNUSCo-Diagnostics, Inc. Announces Third Quarter 2023 Earnings..
23/10/202315:30PRNUSCo-Diagnostics, Inc. to Host Booth at CASMET Symposium..
16/10/202315:30PRNUSCo-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in..
27/9/202315:30PRNUSCo-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL..
22/9/202315:30PRNUSCo-Diagnostics, Inc. to Participate in 6th ACTC Conference..
21/9/202315:30PRNUSCo-Diagnostics, Inc. to Participate in Gilmartin Group..
07/9/202315:30PRNUSCo-Diagnostics, Inc. to Participate in the H.C. Wainwright..
31/8/202322:05EDGAR2Form 8-K - Current report
29/8/202315:30PRNUSCo-Diagnostics, Inc. Appoints Chief Regulatory Affairs..
18/8/202315:30PRNUSCo-Diagnostics, Inc. to Present at 15th Next Generation Dx..
16/8/202317:30PRNUSCo-Diagnostics, Inc. to Host Booth at Medlab Asia Conference..
10/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:03EDGAR2Form 8-K - Current report
10/8/202322:01PRNUSCo-Diagnostics, Inc. Reports Second Quarter 2023 Financial..
27/7/202315:30PRNUSCo-Diagnostics, Inc. Announces Second Quarter 2023 Earnings..
20/7/202315:30PRNUSCo-Diagnostics, Inc. to Host Booth and Discuss Recent Grant..
20/7/202312:10EDGAR2Form DEF 14A - Other definitive proxy statements
18/7/202315:30PRNUSCo-Diagnostics, Inc. Announces Recent Grant Awards
13/7/202315:30PRNUSCo-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home..
Apertura: 1,56 Min: 1,4276 Max: 1,59
Chiusura: 1,59

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network